Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702-Reference-Cited by-同舟云学术

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702

Published:2007-06-19 Issue:2 Volume:97 Page:162-169
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Okamoto H, ,Watanabe K,Kunikane H,Yokoyama A,Kudoh S,Asakawa T,Shibata T,Kunitoh H,Tamura T,Saijo N

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603810.pdf

Reference30 articles.

1. Ardizzoni A, Favaretto A, Boni L, Baldini E, Castiglioni F, Antonelli P, Pari F, Tibaldi C, Altieri AM, Barbera S, Cacciani G, Raimondi M, Tixi L, Stefani M, Monfardini S, Antilli A, Rosso R, Paccagnella A (2005) Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis-A Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study. J Clin Oncol 23: 569–575

2. Carney DN (1995) Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer. Lung Cancer 12 (Suppl 3): S77–S83

3. DeMets DL, Lan KK (1994) Interim analysis: the alpha spending function approach. Stat Med 13: 1341–1352

4. Evans WK, Radwi A, Tomiak E, Logan DM, Martins H, Stewart DJ, Goss G, Maroun JA, Dahrouge S (1995) Oral etoposide and carboplatin: effective therapy for elderly patients with small cell lung cancer. Am J Clin Oncol 18: 149–155

5. Findlay MP, Griffin AM, Raghavan D, McDonald KE, Coates AS, Duval PJ, Gianoutsos P (1991) Retrospective review of chemotherapy for small cell lung cancer in the elderly: dose the end justify the means? Eur J Cancer 27: 1597–1601

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric oncology in the most aged societies;Japanese Journal of Clinical Oncology;2024-07-22

2. Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer;International Journal of Clinical Oncology;2024-07-15

3. Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center;Cancers;2024-05-21

4. Comparison of Irinotecan/carboplatin versus Etoposide/carboplatin for extended disease small cell lung cancer (ED-SCLC): A systematic review and meta-analysis of randomized controlled trials;2024-03-07

5. Recent advances and future strategies in first-line treatment of ES-SCLC;European Journal of Cancer;2024-03